Methylnaltrexone is safe in cancer patients with peritoneal carcinomatosis

Opioid-induced constipation (OIC) has become increasingly prevalent with the rise of prescription opioid use and can significantly impact quality of life, especially in patients with advanced illness. Methylnaltrexone has proven effective in treating cancer patients with OIC who have not responded a...

Descripción completa

Detalles Bibliográficos
Autores principales: Nelson, Kirbylee K., Schattner, Mark A., Mendelsohn, Robin B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610621/
https://www.ncbi.nlm.nih.gov/pubmed/31270339
http://dx.doi.org/10.1038/s41598-019-44864-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610621/
https://www.ncbi.nlm.nih.gov/pubmed/31270339
http://dx.doi.org/10.1038/s41598-019-44864-2

Ejemplares similares